Menu Search

BB Biotech AG

BION:SWX

BB Biotech AG

Actions
  • Price (CHF)45.25
  • Today's Change0.20 / 0.44%
  • Shares traded10.21k
  • 1 Year change+18.46%
  • Beta0.9093
Data delayed at least 15 minutes, as of Feb 17 2026 09:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CHFView more

In 2024, cash reserves at BB Biotech AG fell by 43.00k. However, the company earned 304.56m from its operations for a Cash Flow Margin of 271.35%. In addition the company used on investing activities and also paid 305.20m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share41.83
Tangible book value per share41.83
More ▼

Balance sheet in CHFView more

SmartText is unavailable
Current ratio631.70
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in CHF

Year on year, growth in dividends per share fell -10.00% while earnings per share excluding extraordinary items rose 136.75%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)4.95%
Div growth rate (5 year)-11.94%
Payout ratio (TTM)60.03%
EPS growth(5 years)-35.32
EPS (TTM) vs
TTM 1 year ago		32.97
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.